Pathology Trailblazers

Breast Cancer

ASCP Pathology Trailblazers in HER2-low Breast Cancer

In 2022, ASCP, working in collaboration with Q Synthesis LLC, invited pathologists to participate in a unique cohort-based leadership development CME program called Pathology Trailblazers: HER2-low Breast Cancer Collaborative Learning Exchange.

This program began in May 2022 and ran for approximately 3 months. Details and findings from the program are below.

Participation Details:

Using case studies and facilitated discussion, program faculty guided participants through a leadership framework that outlined how to prepare for the emerging category of HER2-low breast cancer.
Participants committed to demonstrating personal leadership growth and development through this program.
ASCP held two (2) CME virtual meetings where participants engaged in group dialogue. Each meeting lasted 60 minutes.
Participants were able to claim CME credits for completing the program.

To learn more about how the participants implemented their action plans, please view the project summaries below.

Download Project Summary (pdf)

First Name *
Last Name *
Email *
Customer ID

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id